Literature DB >> 26912317

Differential T Cell Cytokine Receptivity and Not Signal Quality Distinguishes IL-6 and IL-10 Signaling during Th17 Differentiation.

Lindsay L Jones1, Rajshekhar Alli1, Bofeng Li1, Terrence L Geiger2.   

Abstract

How a large number of cytokines differentially signal through a small number of signal transduction pathways is not well resolved. This is particularly true for IL-6 and IL-10, which act primarily through STAT3 yet induce dissimilar transcriptional programs leading alternatively to pro- and anti-inflammatory effects. Kinetic differences in signaling, sustained to IL-10 and transient to IL-6, are critical to this in macrophages. T cells are also key targets of IL-6 and IL-10, yet how differential signaling in these cells leads to divergent cellular fates is unclear. We show that, unlike for macrophages, signal duration cannot explain the distinct effects of these cytokines in T cells. Rather, naive, activated, activated-rested, and memory CD4(+) T cells differentially express IL-6 and IL-10 receptors in an activation state-dependent manner, and this impacts downstream cytokine effects. We show a dominant role for STAT3 in IL-6-mediated Th17 subset maturation. IL-10 cannot support Th17 differentiation because of insufficient cytokine receptivity rather than signal quality. Enforced expression of IL-10Rα on naive T cells permits an IL-10-generated STAT3 signal equivalent to that of IL-6 and equally capable of promoting Th17 formation. Similarly, naive T cell IL-10Rα expression also allows IL-10 to mimic the effects of IL-6 on both Th1/Th2 skewing and Tfh cell differentiation. Our results demonstrate a key role for the regulation of receptor expression rather than signal quality or duration in differentiating the functional outcomes of IL-6 and IL-10 signaling, and identify distinct signaling properties of these cytokines in T cells compared with myeloid cells.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26912317      PMCID: PMC4799746          DOI: 10.4049/jimmunol.1402953

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  SOCS proteins, regulators of intracellular signaling.

Authors:  X P Chen; J A Losman; P Rothman
Journal:  Immunity       Date:  2000-09       Impact factor: 31.745

2.  IL-1β and TGF-β act antagonistically in induction and differentially in propagation of human proinflammatory precursor CD4+ T cells.

Authors:  Katrin Hebel; Marion Rudolph; Bernhard Kosak; Hyun-Dong Chang; Jana Butzmann; Monika C Brunner-Weinzierl
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

3.  SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.

Authors:  J Schmitz; M Weissenbach; S Haan; P C Heinrich; F Schaper
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation.

Authors:  David A Braun; Miguel Fribourg; Stuart C Sealfon
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

Review 5.  Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancer.

Authors:  Linda A Feagins
Journal:  Inflamm Bowel Dis       Date:  2010-11       Impact factor: 5.325

Review 6.  Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.

Authors:  Peter J Murray
Journal:  Curr Opin Pharmacol       Date:  2006-05-18       Impact factor: 5.547

7.  Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.

Authors:  Lynn Williams; Laura Bradley; Alexandra Smith; Brian Foxwell
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  Measurement of interleukin-17.

Authors:  Bhanu P Pappu; Chen Dong
Journal:  Curr Protoc Immunol       Date:  2007-11

Review 9.  The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain.

Authors:  Raymond P Donnelly; Faruk Sheikh; Sergei V Kotenko; Harold Dickensheets
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

10.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

View more
  11 in total

1.  IL-6 Promotes T Cell Proliferation and Expansion under Inflammatory Conditions in Association with Low-Level RORγt Expression.

Authors:  Bofeng Li; Lindsay L Jones; Terrence L Geiger
Journal:  J Immunol       Date:  2018-10-12       Impact factor: 5.422

2.  Generation of T Cell Receptor Retrogenic Mice.

Authors:  Yuelin Kong; Yi Jing; Maria Bettini
Journal:  Curr Protoc Immunol       Date:  2019-05-15

3.  Electro-acupuncture at Acupoint ST36 Ameliorates Inflammation and Regulates Th1/Th2 Balance in Delayed-Type Hypersensitivity.

Authors:  Zhigang Wang; Tao Chen; Man Long; Longyun Chen; Lei Wang; Nina Yin; Zebin Chen
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

4.  Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients.

Authors:  Kirstin Harling; Ernest Adankwah; Alptekin Güler; Anthony Afum-Adjei Awuah; Louis Adu-Amoah; Ertan Mayatepek; Ellis Owusu-Dabo; Norman Nausch; Marc Jacobsen
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

5.  Hexokinase II may be dispensable for CD4 T cell responses against a virus infection.

Authors:  Siva Karthik Varanasi; Ujjaldeep Jaggi; Nissim Hay; Barry T Rouse
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 6.  Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy.

Authors:  Grégory Verdeil; Toby Lawrence; Anne-Marie Schmitt-Verhulst; Nathalie Auphan-Anezin
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

7.  B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's Disease.

Authors:  Olfa Maghrebi; Meriam Belghith; Cyrine Jeridi; Amine Rachdi; Fatma Nabli Fatnassi; Zakaria Saied; Samir Belal; Samia Ben Sassi; Mohamed-Ridha Barbouche
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

8.  Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.

Authors:  Andrew M Donson; John Apps; Andrea M Griesinger; Vladimir Amani; Davis A Witt; Richard C E Anderson; Toba N Niazi; Gerald Grant; Mark Souweidane; James M Johnston; Eric M Jackson; Bette K Kleinschmidt-DeMasters; Michael H Handler; Aik-Choon Tan; Lia Gore; Alex Virasami; Jose Mario Gonzalez-Meljem; Thomas S Jacques; Juan Pedro Martinez-Barbera; Nicholas K Foreman; Todd C Hankinson
Journal:  J Neuropathol Exp Neurol       Date:  2017-09-01       Impact factor: 3.685

Review 9.  Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.

Authors:  Liang Guo; Chuanlei Wang; Xiang Qiu; Xiaoyu Pu; Pengyu Chang
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

10.  Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-κB and PPAR-γ pathways.

Authors:  Maged E Mohamed; Sahar A Elsayed; Hafez R Madkor; Heba M Saad Eldien; Omar M Mohafez
Journal:  Intest Res       Date:  2020-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.